The pros and cons and timing of therapeutic intervention should be established by certain indicators, such as the FRAX and serum IGF-1 level, to rationally prevent the development of osteoporosis and fracture in patients with PBC. This evidence concerns the gene IGF1 and primary biliary cholangitis.